Cryptococcal Disease and the new PEPFAR Technical Considerations:
Cryptococcal disease has recently been included in the Technical Considerations Provided by PEPFAR Technical Working Groups for FY 2013 COPS and ROPS, October 2012 (page 96,98 and 105). The Screening and treatment to prevent Cryptococcal Meningitis (CM) intervention (or approach) is now listed among the recommended Care and Support Services with supporting evidence of potential public health impact, particularly regarding morbidity and mortality.
For detailed information also available on the PEPFAR website: click here

October 28, 2012

The Antifungal Therapeutic effects of Sertraline in HIV-infected adults with Cryptococcal Meningitis: click here
Reconsidering Cryptococcal Antigen Screening in the U.S. among persons with CD4<100 cells/mcL: c lick Here

August 1, 2012Highlights from the 2012 International AIDS Conference, Washington D.C., July 22-27